What does VIDA invest in?
VIDA invests most often at Series B and Seed (80% of the rounds on record), in sectors such as Clinical Trial Imaging, Ai-powered Digital Biomarkers and Drug Development.
United States · Investor
Last cheque observed Feb 2019. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.
QuietCompanyWebsite unconfirmed
5 rounds on record
Mostly Series B and Seed: 80% of its rounds
A website was listed for this organisation, but we could not confirm it belongs to the firm that wrote these cheques. Either the site never mentions them, or it turned out to be a different company sharing the name. We show neither it nor anything read from it. Tell us the right one.
Every round we can evidence, newest first5 appearances
1 round
2 rounds
2 rounds
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The latest companies VIDA put money into.
VIDA invests most often at Series B and Seed (80% of the rounds on record), in sectors such as Clinical Trial Imaging, Ai-powered Digital Biomarkers and Drug Development.
5 investments on record, 0 of them in the last 12 months. The most recent was in Feb 2019.
Its most recent investments on record: Oyster Point (Series B, Feb 2019), Sutro (Series E, Jun 2018) and Kronos Bio (Seed, May 2018).
The median round it joins is $84M.
Rarely, if at all: none of its 5 investments on record names it as the lead.
Most of the companies it backs are in the United States (100%).
No investments in the last 12 months; the latest was in Feb 2019.
VIDA is a company based in United States.
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it